Frankenthal, Germany -- RKW reports high demand for its viral barrier film-to-nonwoven laminate for surgical gowns during the MEDICA, the world's largest medical fair show, which took place in Dusseldorf from 12th to 15th November 2014.
Having launched Medicace G82 at Index 2014 in Geneva earlier this year as a barrier product which is not only fully breathable but also impervious to viruses and blood-borne pathogens (ASTM 1671 and 1670), interest in this laminate was already high, both from Brand owners and convertors of surgical gowns. The recent Ebola crisis has, not surprisingly, provoked an immediate and more urgent demand for this product.
Medicace G82 complements its sister, G72, which offers an ideal solution in breathable barrier laminates for gowns that are worn during long periods of time. The added value of G82 is that it offers not only a bacteria barrier but also a viral barrier, to be worn in the most difficult of situations.
“Whilst we were prepared for high demand, we did not envisage such heavy traffic on our Stand for discussions on Ebola” says Sophie Litt, Sales Manager Medical Films at RKW. She adds “As a result, we have immediately introduced this product into our Industrial portfolio for protective workwear.”
The RKW Group
- The RKW Group is one of the leading international manufacturers of high-quality plastic films and nonwovens.
- On an annual basis, more than 3,000 employees process over 420,000 tons of plastic materials in 23 locations around the world.
- The RKW Group offers a broad range of product and service solutions in films and nonwovens for the hygiene and medical field, for the converting industry, for industrial and consumer packaging as well as for the agricultural and construction sectors.
- For almost 60 years, the RKW Group has been setting standards in terms of quality, innovation, and service from which our local and global customers benefit.
- The independent, family-owned company generated sales of 860 million euros in 2013. For 2014, the company plans on achieving sales of 950 million euros.